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Abstract 
Introduction: Maternal vaginal colonization by Streptococcus agalactiae (GBS) has an important impact on neonatal health but has not been 
studied in the Democratic Republic of Congo. The aim of this study was to determine its frequency and influencing factors. 
Methodology: Vaginal samples (n = 509) for bacteriological analysis were collected from women in Bukavu, eastern DR Congo, during their 
third trimester of pregnancy, along with information about age, education and socio-economic status, and medical and obstetric-
gynecological history. 
Results: The overall GBS colonization rate was 20%. Colonization was significantly associated with low education, history of urinary 
infection during the pregnancy, history of premature childbirth or abortion, and HIV-positive serology, but was not significantly associated 
with socio-economic level or parity. 
Conclusions: The GBS colonization rate is similar to that found elsewhere on the continent. Further studies, with follow-up of neonates of 
infected mothers and evaluation of prevention/treatment strategies, are needed. 
 
Key words: Streptococcus B; vaginal; colonization; pregnancy. 
 
J Infect Dev Ctries 2014; 8(9):1195-1200. doi:10.3855/jidc.5030 
 
(Received 24 March 2014 – Accepted 23 June 2014) 
 
Copyright © 2014 Mitima et al. This is an open-access article distributed under the Creative Commons Attribution License, which permits unrestricted use, 
distribution, and reproduction in any medium, provided the original work is properly cited. 
 
Introduction 
Streptococcus agalactiae is a Gram-positive 
bacterium belonging to Lancefield’s group B 
streptococci (GBS). It is responsible for invasive 
infections mainly in pregnant women and infants [1,2]; 
it has been implicated in maternal infections such as 
endometritis, chorio-amniotitis, and puerperal 
infections of the uro-genital tract, as well as in 
neonatal pneumonia, meningitis, and septicemia [3]. 
Given this pathogenic role and the relatively frequent 
vaginal colonization with GBS, screening strategies 
have been proposed in several countries around the 
world, with the view to initiate prevention during the 
third trimester of pregnancy [3] or intrapartum 
treatment to avoid mother-to-newborn transmission 
[4]. In most countries in Africa, and in the Democratic 
Republic of Congo (DRC) in particular, due to the lack 
of a national policy for systematic screening of GBS 
carriage, no data on prevalence, mortality, and risk 
factors of this colonization have been reported to date. 
Yet, the neonatal mortality in these countries remains 
high. Indeed, the DRC is among the 12 countries in the 
world where neonatal mortality is greater than 39 per 
1,000 living births [5]. In the specific context of 
developing countries, where hygiene and diagnostic 
conditions can be poor, it is not known to what extent 
a mother’s colonization by GBS might be linked to 
adverse pregnancy outcomes or to the high rates of 
neonatal diseases. It is with this perspective that we 
conducted this study, in order to provide preliminary 
data for the public health issue of possible infectious 
causes of the high neonatal mortality. The aim of this 
study was, therefore, to assess the prevalence of GBS 
vaginal colonization among pregnant women attending 
prenatal care in selected healthcare centers within the 
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city of Bukavu, Province of South-Kivu, in the eastern 
part of the DR Congo. 
 
Methodology 
The study was carried out in accordance with the 
ethical standards set out by the Declaration of Helsinki 
and in agreement with local institutional ethical 
guidelines. 
This was a prospective cross-sectional study. It 
was conducted for one year, starting from 1 June 2012 
to 31 May 2013, in 12 healthcare centers of Bukavu (4 
in the health zone of Kadutu: Cimpunda, Uzima, 
CBCA Nyamugo, and Maria; 4 in the health zone of 
Bagira: Bagira, Nyamuhinga, Burhiba, and 
Mushekere; and 4 in the health zone of Ibanda: Panzi 
Hospital, Malkia wa Amani, 8th CEPAC Chahi, and 
Cidasa). The total population covered by these health 
centers was 272,804, representing 27.6% of the whole 
population (987,592 inhabitants) of this urban 
environment. Sampling was exhaustive; vaginal 
samples were collected from all eligible pregnant 
women attending prenatal care in the last trimester of 
their pregnancies who gave informed consent. Women 
with genital fistulae and those taking antibiotics were 
excluded from the study. The following information 
was also collected through direct interview of the 
women: age, education, and socio-economic level 
(based on household income), medical and 
gynecological-obstetric history, including parity, uro-
genital tract infections during the current pregnancy, 
and results of previous HIV screening. Bacteriological 
sample collection was done using a sterile cotton swab 
inserted into the vaginal cavity through a speculum’s 
opening. Swabs were immersed in sterile transport 
media (Portagerm, BioMérieux, Marcy l'Etoile, 
France) and were sent to the laboratory in a box 
insulated with ice packs within a maximum of three 
hours. In the laboratory, each swab was inoculated 
immediately on a culture medium made of blood agar 
containing nalidixic acid (15 mg/mL) and colistin (10 
µg/mL). The culture dishes were incubated at 37°C 
under CO2 for 48 hours, with readings done every 24 
hours. When beta-hemolytic colonies appeared within 
24-48 hours of incubation under CO2, Gram staining 
was performed, followed by a catalase test, a hippurate 
test, and a Christie-Atkins-Munch-Petersen (CAMP) 
test using a Staphylococcus aureus strain. The catalase 
test was performed as follows: a drop of 10% 
hydrogen peroxide (H2O2) was placed on a microscope 
glass slide; a sample of the beta-hemolytic colony was 
collected using a cooled sterile loop, and was added to 
and mixed with the H2O2 drop. The formation 
(positive reaction) or absence (negative reaction) of air 
bubbles was monitored. The hippurate test, aimed at 
detecting the presence of hippurate hydrolases, was 
performed using a rapid test kit (Mast Diagnostic, 
Amiens, France) according to the supplier’s 
instructions as follows: an organism suspension with 
density corresponding to the McFarland standard no. 5 
was prepared in Mast Peptone Water DM185 liquid 
growth medium; 0.5 mL of the bacterial suspension 
was added to a sterile, otherwise fully sealed, 
hippurate-containing tube (supplied as part of the kit), 
shaken gently and incubated at 37°C for 4 hours; two 
drops of Ninhydrin development reagent (also part of 
the kit) were added without shaking. The mixture was 
kept at room temperature for 15 minutes. The 
appearance (positive reaction) or absence (negative 
reaction) of a violet color was monitored. The CAMP 
test, which is based on the fact that group B hemolytic 
Streptococcus displays satellitism with S. aureus, was 
performed as follows: S. aureus was inoculated in a 
blood-based culture medium in a straight line or 
streak; GBS suspect colony was inoculated in the same 
medium using a streak perpendicular to the first one. 
Enhanced hemolysis by S. aureus was induced at the 
junction between the two streaks, forming a half-moon 
or arrowhead image. Only Gram-positive colonies 
giving a negative catalase reaction were further 
identified by the hippurate and CAMP tests. At the 
end, the Lancefield serological grouping was 
performed by an anti-B latex agglutination test (Slidex 
Strepto-Kit, BioMérieux). This test was performed as 
follows: a dense (2-3 colonies) bacterial suspension 
was made in 0.5 mL of a medium containing surface 
antigen extraction enzyme; the suspension was kept at 
42°C for at least 15 minutes; a drop of a medium 
containing latex and one of the six (A, B, C, D, F, G) 
groups of antibodies was placed on a piece of 
cardboard with a black background; then a drop of the 
extraction suspension was added and mixed for about 
1 minute. The appearance of agglutination in the drop 
identified the Streptococcus group corresponding to 
the antibody used. 
Statistical analysis of the data was made using the 
EPI INFO software, version 3.4.1. Association of GBS 
infection with any risk factor was analyzed by 
calculating the odds ratio (OR), with a confidence 
interval of 95% (95% CI). Associations that gave an 
OR greater than 1 with a P value of less than 0.05 
were considered significant. 
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Results 
During the study period, 731 visits for last 
trimester prenatal care took place in the 12 selected 
health centers. Of those women, 178 were excluded 
and 44 of the 553 eligible candidates did not consent 
to the study. Therefore, bacteriological samples were 
collected from 509 pregnant women who agreed to 
participate to the screening. 
Table 1 presents the socio-demographic 
distribution of the patients, grouped according to 
health zone. As expected, the majority of the pregnant 
women were between 18 and 35 years of age. 
However, nearly one-quarter (24%) were older than 35 
years and 10% were younger than 18 years of age. 
Primiparae represented only 35% of the pregnant 
women. Two other social variables analyzed were 
education and socio-economic level. Most (64%) of 
the women had reached the secondary school 
education level and could be considered to be literate. 
Nevertheless, 71% of the pregnant women had a very 
low socio-economic status and were without an 
identifiable income source. 
Table 2 shows the average prevalence of vaginal 
colonization with GBS in the three health zones. The 
overall prevalence was 20%, with no difference 
between the three city areas (19% in Ibanda, 20% in 
Kadutu, and 21% in Bagira). History collected by a 
simple questionnaire indicated that only 18 women 
(4%) had tested positive for HIV in this sample. 
Similarly, 12% of the women reported a history of 
previous spontaneous abortion and/or premature 
delivery. Finally, almost one-third (29%) had had a 
history of urinary tract infections during the current 
pregnancy. 
From univariate analysis of the results, as shown in 
Table 3, factors associated with a significant risk (p < 
0.05) of vaginal colonization with GBS were, in 
ascending order: a low education level (OR: 2.5; 95% 
CI: 1.57-3.97), a history of urinary tract infection 
during the pregnancy (OR: 3.97; 95% CI: 2.46-6.39), a 
Table 1. Grouping of the pregnant women according to age, parity, education level, and socio-economic status 
Parameter 
Kadutu 
n = 273 
Bagira 
n = 121 
Ibanda 
n = 115 
Total 
N = 509 (%) 
Age  
< 18 years  34 11 6 51 (10) 
18 – 35 years 182 78 77 337 (66) 
> 35 years 57 32 32 121 (24) 
Parity  
Primiparae 93 45 38 176 (35) 
Multiparae 180 76 77 333 (65) 
Education level  
≤ Primary 93 59 33 185 (36) 
≥ Secondary 180 62 82 324 (64) 
Socio-economic level  
Low 188 85 89 362 (71) 
Middle 85 36 26 147 (29) 
Low income: household with a total monthly income of less than USD 100; Middle income: household with monthly income between USD 100 and 300; 
There were no cases of high income (greater than USD 300 per month) households. 
 
Table 2. Medical history and GBS colonization in the three different health zones of the city of Bukavu 
Parameter 
Kadutu 
n = 273 
Bagira 
n = 121 
Ibanda 
n = 115 
Total 
N = 509 (%) 
Urinary tract infections during the pregnancy  
Yes 92 25 29 146 (29) 
No 181 96 86 363 (71) 
Abortion and/or premature delivery  
Yes 36 15 12 63 (12) 
No 237 106 103 446 (88) 
HIV serological status  
Positive 10 4 4 18 (4) 
Negative 263 117 111 491 (96) 
GBS vaginal colonization  
Yes 55 26 22 103 (20) 
No 218 95 93 406 (80) 
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positive HIV test (OR: 4.22; 95% CI: 1.49-11.97), and 
a history of spontaneous abortion or premature 
delivery (OR: 8.19; 95% CI: 4.49-15.01). In contrast, 
the young age of the pregnant women and their parity 
or socio-economic status were not found to be 
correlated (OR < 1; p > 0.05) with the prevalence of 
vaginal colonization with GBS during the third 
trimester of pregnancy. 
 
Discussion 
The impact of female genital colonization with 
GBS during pregnancy on maternal and neonatal 
health is now well recognized and has been the focus 
on extensive research work in developed countries. 
However, considerably fewer studies have been 
conducted in African countries. The present study is 
the first one investigating GBS in a population of the 
DRC. 
The majority of pregnant women included in this 
study were between 18 and 35 years of age. This age 
range corresponds to the reproductive period of 
women in most of developing countries. A significant 
percentage (10%) of the participants were under 18 
years of age, below the age when marriage is usually 
legally authorized, probably as a result of uncontrolled 
rural-to-urban exodus and increased urban promiscuity 
in a post-conflict context (marked by poverty and 
increased sexual violence) such as the one prevailing 
in the area of this study. About two-thirds of our 
respondents were multiparae, and there was a similar 
proportion of women with an education level equal to 
or greater than secondary level. This indicates that the 
majority of the women were likely to be well informed 
about pregnancy and hygiene. More than 70% of our 
respondents were of a low socio-economic status (with 
a family income of less than USD 100 a month for a 
general average of six individuals per family). This 
does not necessarily imply that the patients belonged 
mostly to the poorest section of the local population, 
as poverty and unemployment are general hallmarks of 
the population in the DRC. 
Our findings reveal an average rate of colonization 
of 20% in pregnant women in the city of Bukavu. The 
rate appears uniform in all the three health zones of the 
city. Different colonization rates have been observed 
in various studies throughout the world, with 
prevalence of asymptomatic GBS carriage ranging 
over one order of magnitude, from < 3% to > 30% 
[2,6,7]. The colonization rate does not seem to be 
related to the socio-economic development of the 
country. An American study reported a vaginal 
carriage rate of GBS of 15.6% among women at 23-26 
weeks gestational age [8]. On the European continent, 
the GBS carriage rate by pregnant women has also 
Table 3. Association between various factors and GBS colonization 
Studied variables  
GBS carriage 
n = 103 
No GBS carriage  
n = 406 
OR 95% CI P 
Age 
18 years – 35 years 63 274 0.76 0.47 – 1.22 0.22 
< 18 years and > 35 years 40 132    
Parity 
Multiparae 64 269 0.84 0.52 – 1.34 0.43 
Primiparae 39 137    
Education level 
≤ Primary 53 121 2.50 1.57 – 3.97 0.00003 
≥ Secondary 50 285    
Socio-economic level 
Low 58 304 0.43 0.27 – 0.69 0.0002 
Middle 45 102    
Urinary tract infections during the pregnancy 
Yes 55 91 3.97 2.46 – 6.39 0.0000000 
No 48 315    
Abortion and/or premature delivery 
Yes 37 26 8.19 4.49 – 15.01 0.0000000 
No 66 380    
HIV positive 
Yes 9 9 4.22 1.49 – 11.97 0.001 
No 94 397    
Results of univariate analysis. Odds ratios (OR), with confidence intervals of 95% (95% CI), were calculated. 
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varied between different studies, even between 
countries sharing geographical proximity and similar 
socio-economic conditions (e.g., rates of 10% in 
France vs. 23.7% in Belgium) [9]. In developing 
countries, the prevalence of genital and anal carriage 
of GBS has been also reported to vary between 1% 
and > 30% [6]; further examples can be found in the 
works of  Mavenyengwa et al. [10] and Sharmila et al. 
[11]. Given these differences, standardized screening 
methods have been proposed because part of the 
reported variations may reflect differences in 
methodology rather than possible real differences in 
prevalence. However, in general, prevalence rates on 
the African continent seem to be similar to those of 
developed countries [12]. In Morocco, one study 
found asymptomatic carriage rate of 23.3% [3]. 
Similar or higher rates were found in Southern Africa 
[10,12-14]. Our study, which is the first on this topic 
to be conducted in the DRC, had similar results. In the 
city of Bukavu, urinary tract infections during 
pregnancy, miscarriage, and premature birth history 
were associated with a high odds ratio for vaginal 
colonization in pregnant women. In this respect, our 
findings confirm those of other studies in Tunisia, in 
which a statistically significant association between 
GBS carriage and genital tract infections during 
pregnancy was found [15]. In contrast, other studies 
from Tunisia and from Morroco did not find any 
association with the following risk factors: age, school 
education level, parity, history of abortion or 
spontaneous miscarriage, history of extra-uterine 
pregnancy, fatal death in utero, preterm pyelonephritis, 
gestational diabetes, and twin pregnancy [3,15,16]. 
Our study highlights the association of GBS 
vaginal colonization with HIV seropositivity. 
Although the association with HIV reported here 
might have been underestimated because HIV-positive 
status was based on history of tests carried out 
previous to this study, the finding is in agreement with 
the results of studies in Burkina Faso [17] and 
Zimbabwe [10], which also found a higher prevalence 
of GBS in pregnant women infected with HIV. 
However, such an association was not found in all 
previous studies [13,18]. The reasons for these 
discrepancies remain unclear. As far as the present 
study is concerned, one limitation about the strength of 
the correlation found is the low number of HIV-
positive patients (18 out of 509). The prevalence (4%) 
of HIV among the pregant women is in agreement 
with the rate in the general local population (3.5%; 
Panzi Hospital unpublished data). Larger numbers of 
pregnant women will be needed to further test this 
correlation. 
As stated earlier, the relatively high rate of vaginal 
colonization with GBS and its pathogenicity have 
justified the implementation of screening, prevention, 
and treatment strategies [2,4,7,12]. Clinical practice 
guidelines have advocated intrapartum antibiotherapy 
to prevent GBS infection of the neonate, but the 
expected prevention of late-onset neonatal infection 
does not seem to be supported by conclusive data [4]. 
Currently, in Bukavu and elsewhere in the DRC and 
many other African countries, maternal intrapartum 
antibiotic or alternative treatments such as 
chlorhexidine irrigation are not part of the local 
clinical guidelines. Because the issue about the 
usefulness of current anti-GBS preventive or 
therapeutic pharmacological measures remains 
unresolved, it is important to analyze the impact of 
GBS in the specific context of low-income countries 
[6] such as the DRC, where the high fertility rate 
(more than six births per woman) may facilitate further 
testing of prevention measures.  
The present study involved only an urban 
population; it will be of interest, therefore, to 
investigate some representative rural areas. Although 
data such as those of the present study are only 
descriptive, they may nevertheless be useful, as they 
can constitute the basis for an eventual intervention 
study on preventive and therapeutic measures against 
neonatal infection. In the unique environment of the 
DRC, the risk/benefit ratio of such measures has not 
been evaluated and might be different from those in 
more developed environments. Given that the DRC 
has a very high neonatal mortality rate, and that data 
elsewhere suggest that neonates with GBS from 
maternal transmission present with exceptionally high 
infection risks [19], the results of the present study 
could set the stage for a good intervention study to 
resolve the issue of ante- or intrapartum treatment 
risk/benefit ratio, or to test the effect of vaccination. 
 
Conclusions 
Vaginal colonization with Streptococcus 
agalactiae (GBS) is frequent among pregnant women 
in the city of Bukavu. Risk factors associated with this 
condition are low level of education, genito-urinary 
tract infections during pregnancy, HIV infection, and 
history of abortion and/or of premature delivery. The 
negative impact of GBS colonization has not been 
fully clarified, especially in countries where hygiene 
might be poor. Additional studies are needed to follow 
up the fate of pregnancies and the status of neonates 
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born to mothers colonized by GBS. Such studies are 
needed to allow policy decision on the usefulness of 
screening, prevention, and treatment strategies. 
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